• Listed Companies
  • Announcements
  • TIANJIN DEV
  • EN
  • 繁
  • 简
  • Dec 14, 2023
    06:17

    Potential Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.

    Inside Information

    00882 - TIANJIN DEV


  • Dec 12, 2023
    06:28

    An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

    Overseas Regulatory Announcement - Other

    00882 - TIANJIN DEV


  • Dec 11, 2023
    19:56

    Connected Transaction - Formation of Limited Partnership Fund

    Connected Transaction

    00882 - TIANJIN DEV


  • Dec 05, 2023
    18:20

    Poll Result of the Extraordinary General Meeting held on 5 December 2023

    Results of EGM/SGM

    00882 - TIANJIN DEV


  • Nov 13, 2023
    21:46

    Change of Deadline for Lodging of the Form of Proxy for the Extraordinary General Meeting to be held on 5 December 2023

    Notice of EGM/SGM

    00882 - TIANJIN DEV


  • Nov 09, 2023
    18:51

    Notice of Extraordinary General Meeting

    Closure of Books or Change of Book Closure Period

    00882 - TIANJIN DEV


  • Nov 09, 2023
    18:48

    Form of Proxy for Extraordinary General Meeting to be held on 5 December 2023

    Proxy Forms

    00882 - TIANJIN DEV


  • Nov 09, 2023
    18:46

    Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary General Meeting

    Documents on Display

    00882 - TIANJIN DEV


  • ‹
  • 1
  • 2
  • ...
  • 7
  • 8
  • 9
  • ...
  • 57
  • 58
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2025 All right reserved.